Bavarian Nordic
Pre-Approval PRO BETAPipeline by Phase
Therapeutic Focus
Clinical Trials (43)
A Safety and Immunogenicity Study of CHIKV VLP Vaccine in Children.
Started: 6/5/2025
An Efficacy, Safety, and Immunogenicity Study of CHIKV VLP Vaccine for the Prevention of Chikungunya Disease in Adolescents and Adults
Started: 5/1/2026
Long-term Follow-up Study to Evaluate Safety and Immunogenicity of PXVX0317 Single or Booster Vaccination
Started: 8/30/2023
ABNCoV2 Vaccine in Adult Subjects Previously Vaccinated for SARS-CoV-2
Started: 8/30/2022
Safety and Immunogenicity of CHIKV VLP Vaccine PXVX0317 in Adults ≥65 Years
Started: 5/12/2022
A Phase 3 Trial of the VLP-Based Chikungunya Vaccine PXVX0317 (CHIKV VLP Vaccine)
Started: 9/29/2021
Safety and Efficacy Challenge Study of Live Oral Cholera Vaccine Candidate,PXVX0200, to Prevent Cholera
Started: 9/1/2013
A Study of Live Oral Cholera Vaccine, PXVX200 in Healthy Older Adults
Started: 5/1/2014
A Phase 3 Lot to Lot Consistency Study of Live Oral Cholera Vaccine, PXVX0200 in Healthy Adults
Started: 5/1/2014
Freeze-Dried MVA-BN® Lot Consistency Smallpox Trial
Started: 6/19/2019
A Non-inferiority Trial to Compare MVA-BN® Smallpox Vaccine to ACAM2000®
Started: 3/1/2015
A Randomized, Double-blind, Phase 3 Efficacy Trial of PROSTVAC-V/F +/- GM-CSF in Men With Asymptomatic or Minimally Symptomatic Metastatic Castrate-Resistant Prostate Cancer
Started: 11/28/2011
A Trial to Evaluate Immunogenicity and Safety of Three Consecutive Production Lots of IMVAMUNE® (MVA-BN®) Smallpox Vaccine in Healthy, Vaccinia-naïve Subjects
Started: 2/1/2013
Comparability Trial of the MVA-BN Vaccine Manufactured in Different Production Cells
Started: 10/27/2025
Open-label, Multicenter Immunogenicity and Safety Study of MVA-BN Vaccine in Children From 2 Years to Less Than 12 Years of Age Compared to Adults for the Prevention of Smallpox, Mpox, and Related Orthopoxvirus Infections
Started: 10/21/2024
A Phase 2 Trial in Healthy Adult Participants of the Recombinant MVA-BN-WEV Vaccine
Started: 3/10/2025
Phase 2 Open-label Study of Alum-adjuvanted Chikungunya Virus-like Particle Vaccine (PXVX0317)
Started: 11/20/2019
ABNCoV2 Vaccine in SARS-CoV-2 (COVID-19) Seronegative and Seropositive Adult Subjects
Started: 8/19/2021
Phase 2a Study of MVA-BN-RSV Vaccination and RSV Challenge in Healthy Adults
Started: 2/22/2021
A Study to Assess the Safety and Immunogenicity of PXVX0317 Chikungunya Virus Virus-Like Particle Vaccine
Started: 10/11/2021
Trial of a Chikungunya Vaccine, PXVX0317 CHIKV-VLP, in Healthy Adults
Started: 4/18/2018
CV301 Combined With PD-1/L1 Blockade in Patients With Locally Advanced or Metastatic Urothelial Bladder Cancer
Started: 9/18/2018
A Phase II Trial to Compare a Liquid-frozen and a Freeze-dried Formulation of IMVAMUNE (MVA-BN®) Smallpox Vaccine in Vaccinia-naïve Healthy Subjects
Started: 3/1/2013
RSV-MVA-BN Vaccine Phase II Trial in ≥ 55 Year Old Adults
Started: 9/1/2016
Randomized, Open-label Phase II Trial to Assess the Safety and Immunogenicity of MVA-BN Smallpox Vaccine in Immunocompromised Subjects With HIV Infection
Started: 4/28/2014
An Open-Label Phase II Study to Evaluate Immunogenicity and Safety of a Single IMVAMUNE Booster Vaccination Two Years After the Last IMVAMUNE Vaccination in Former POX-MVA-005 Vaccinees
Started: 8/1/2008
A Study to Evaluate Safety and Immunogenicity of One and Two Doses of IMVAMUNE® Smallpox Vaccine in 56-80 Year Old Vaccinia-experienced Subjects
Started: 6/1/2009
Study to Evaluate Safety, Dose Response and Immunogenicity of the Measles Vaccine MVA mBN85B in Healthy Children Aged 6 Months to 6 Years
Started: 6/1/2009
TAEK-VAC-HerBy Vaccine for Brachyury and HER2 Expressing Cancer
Started: 8/10/2020
Safety and Immunogenicity of the Live Oral Cholera Vaccine Candidate PXVX0200
Started: 4/1/2012
A Phase 1 Open Label Trial of Intravenous Administration of MVA-BN-Brachyury Vaccine in Patients With Advanced Cancer
Started: 1/8/2020
Safety and Tolerability Trial (MVA-BN-Brachyury/FPV-Brachyury)
Started: 1/8/2018
Vaccination Trial of a Recombinant MVA-BN-WEV Vaccine in Healthy Adult Subjects
Started: 10/7/2019
A Trial of CV301 in Combination With Anti-PD-1 Therapy in Subjects With Non-Small Cell Lung Cancer
Started: 12/1/2016
A Safety and Immunology Study of a Modified Vaccinia Vaccine for HER-2(+) Breast Cancer After Adjuvant Therapy
Started: 6/1/2010
A Safety Trial of MVA-BN®-PRO in Men With Androgen-Insensitive Prostate Cancer
Started: 3/1/2008
RSV-MVA-BN Vaccine Phase I Trial, Intranasal Application in Adults.
Started: 9/1/2016
Trial to Evaluate the Safety, Tolerability and Immunogenicity of the Recombinant MVA BN® RSV Vaccine
Started: 8/1/2015
Phase I Safety Study of a Recombinant MVA HIV Multiantigen Vaccine in HIV-infected Subjects
Started: 5/1/2008
VAXCHORA Pediatric Study to Assess Safety and Immunogenicity
Started: 7/21/2017